Insider buying · SEC Form 4

Insider Buying — Aug 14, 2026

Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.

3insider buys
$2.84Mbought in total
3companies
1by CEOs, CFOs and other chiefs
TXOlargest: $2.15M

Every qualifying buy, largest first

StockInsiderValueSharesAvg priceTypeFiled
TXOTXO Partners, L.P.Bob R. SimpsonDirector / 10% Owner$2.15M150,000$14.34AddedAug 13, 2026
Form 4 ↗
Two transactions in one filing: 25,000 shares at $14.43 avg (Aug 12) + 125,000 shares at $14.32 avg (Aug 13), executed in multiple market trades. Serial accumulator — has purchased $33M+ in TXO units YTD. Current price $13.77 (−3.9% from weighted avg buy of $14.34). Post-purchase direct holdings: ~9,500,000 units.
OPFIOppFi Inc.Todd G. SchwartzChief Executive Officer / 10% Owner$428K60,000$7.13AddedAug 13, 2026
Form 4 ↗
Weighted avg $7.128/share, range $7.01–$7.44. Held indirectly through TGS Revocable Trust (Schwartz as sole trustee). Post-purchase indirect holdings: 553,733 shares. Current price $7.13 (flat vs buy). CEO buying at the floor.
GLXYGalaxy Digital Inc.Douglas R. DeasonDirector$258K12,000$21.54AddedAug 14, 2026
Form 4 ↗
Weighted avg $21.536/share, range $21.26–$21.745, executed in multiple trades. Held indirectly via Deason Capital LLC; brings indirect holdings to 71,000 shares (plus 31,348 direct). Transaction date Aug 12, filed Aug 14. Current price $20.95 (−2.7% from buy).

AIThe day in insider buying

SEC Form 4 Insider Scan — August 14, 2026

Scanned the last 24 hours of EDGAR Form 4 filings (Aug 13–14, 2026). 3 qualifying buys (≥ $250K, transaction type P) totalling $2.84M. Insider buying remains sparse — the broader market is running roughly 48 sales for every open-market buy. All three insiders are currently underwater or flat relative to their buy prices.

Headline Filings

  • TXO — Bob R. Simpson (Director / 10% Owner) bought 150,000 common units over two sessions (25K on Aug 12 + 125K on Aug 13) ≈ $2.15M at $14.34 weighted avg; now $13.77 (−3.9% since buy). Serial accumulator: Simpson has purchased $33M+ in TXO units in 2026 alone, steadily boosting his stake toward 16%+. (filing)
  • OPFI — Todd G. Schwartz (CEO / 10% Owner) bought 60,000 shares ≈ $428K at $7.13 weighted avg (range $7.01–$7.44); now $7.13 (flat). CEO buying at the floor after shares have traded sideways in the low-$7s. (filing)
  • GLXY — Douglas R. Deason (Director) bought 12,000 shares ≈ $258K at $21.54 weighted avg (range $21.26–$21.75) via Deason Capital LLC; now $20.95 (−2.7% since buy). Deason has been steadily adding to his Galaxy Digital position, bringing indirect holdings to 71,000 shares. (filing)

Notes

Theme — Energy royalties still getting a bid: TXO Partners (Permian-focused oil & gas production/royalties) continues to attract heavy director buying. Bob Simpson's purchase pattern is non-routine accumulation, not a 10b5-1 plan, executed in multiple market trades. At current $13.77 he's adding to a cost basis that's already well above market, signaling a longer-term conviction view.

Crypto adjacency: Deason's GLXY buy is notable as the smallest qualifying transaction but reflects continued director-level confidence in Galaxy Digital's crypto-native financial services business.

OPFI conviction: The OppFi CEO purchase at exactly the current market price ($7.13) with a range extending below $7.01 suggests he was buying the dip — a constructive signal for a fintech stock that has struggled in the mid-single digits.

Most-bought stocks, last 30 days

  • SCTX $56.3M · 3 buys, 3 insidersScribe Therapeutics Inc.
  • COE $56.2M · 7 buys, 2 insiders51Talk Online Education Group
  • MPLT $15.3M · 1 buyMapLight Therapeutics, Inc.
  • FLUT $11.8M · 1 buyFlutter Entertainment plc
  • LBRX $10.0M · 1 buyLB Pharmaceuticals Inc.
  • BSX $9.00M · 1 buyBoston Scientific Corp
  • PBLS $6.92M · 1 buyParabilis Medicines, Inc.
  • APMD $5.00M · 1 buyApnimed, Inc.
  • BLSM $5.00M · 1 buyBlossomHill Therapeutics, Inc.
  • GSHD $4.49M · 3 buysGoosehead Insurance, Inc.
  • NTSK $3.77M · 1 buyNetskope Inc.
  • TXO $3.58M · 2 buysTXO Partners, L.P.
  • LILA $2.90M · 1 buyLiberty Latin America Ltd.
  • ARTV $2.58M · 1 buyArtiva Biotherapeutics, Inc.
  • LTGO $2.52M · 1 buyLatigo Biotherapeutics, Inc.
  • APTV $2.50M · 1 buyAptiv PLC
  • CSGP $2.49M · 1 buyCoStar Group, Inc.
  • ACI $2.41M · 2 buys, 2 insidersAlbertsons Companies, Inc.
  • NATR $2.32M · 1 buyNature's Sunshine Products, Inc.
  • CLBK $2.13M · 5 buys, 5 insidersColumbia Financial, Inc.

All scans

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.